Does DABIGATRAN ETEXILATE Cause Hypersensitivity? 63 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Hypersensitivity have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.2% of all adverse event reports for DABIGATRAN ETEXILATE.
63
Reports of Hypersensitivity with DABIGATRAN ETEXILATE
0.2%
of all DABIGATRAN ETEXILATE reports
6
Deaths
32
Hospitalizations
How Dangerous Is Hypersensitivity From DABIGATRAN ETEXILATE?
Of the 63 reports, 6 (9.5%) resulted in death, 32 (50.8%) required hospitalization, and 7 (11.1%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for DABIGATRAN ETEXILATE.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Hypersensitivity Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB